Cutler Group LP Mirati Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$41.99 - $62.38 $19,315 - $28,694	460 Added 44.23%	1,500 $88,000
Q3 2023 Nov 07, 2023	SELL	$27.8 - $45.35 $2,780 - $4,535	-100 Reduced 8.77%	1,040 $45,000
Q2 2023 Jul 18, 2023	SELL	$36.13 - $49.49 $3,613 - $4,949	-100 Reduced 8.06%	1,140 $41,000
Q1 2023 May 01, 2023	SELL	$36.54 - $54.26 $159,314 - $236,573	-4,360 Reduced 77.86%	1,240 $46,000
Q4 2022 Feb 07, 2023	BUY	$41.27 - $98.62 $197,270 - $471,403	4,780 Added 582.93%	5,600 $253,000

Q3 2022 Oct 25, 2022	SELL	$59.5 - $86.7 $162,435 - $236,691	-2,730 Reduced 76.9%	820 $57,000
Q2 2022 Aug 04, 2022	SELL	$39.16 - $88.71 $188,633 - $427,316	-4,817 Reduced 57.57%	3,550 $238,000
Q4 2021 Jan 18, 2022	SELL	$132.01 - $190.29 $1.58 Million - $2.28 Million	-11,976 Reduced 58.87%	8,367 $1.23 Million
Q3 2021 Oct 26, 2021	BUY	$132.13 - $177.45 $2.52 Million - $3.38 Million	19,075 Added 1504.34%	20,343 $3.6 Million
Q4 2020 Jan 21, 2021	BUY	$162.05 - $240.27 $17,015 - $25,228	105 Added 9.03%	1,268 $278,000
Q3 2020 Oct 27, 2020	SELL	$113.26 - $167.27 $129,229 - $190,855	-1,141 Reduced 49.52%	1,163 $193,000
Q2 2020 Jul 22, 2020	SELL	$72.01 - $120.39 $259,380 - $433,644	-3,602 Reduced 60.99%	2,304 $263,000
Q4 2019 Feb 06, 2020	BUY	$70.76 - $128.86 $212,704 - $387,353	3,006 Added 103.66%	5,906 $761,000
Q3 2019 Oct 28, 2019	SELL	$77.91 - $109.6 $346,699 - $487,720	-4,450 Reduced 60.54%	2,900 $225,000
Q2 2019 Aug 09, 2019	BUY	$59.49 - $104.71 $389,600 - $685,745	6,549 Added 817.6%	7,350 $757,000
Q4 2018 Feb 05, 2019	SELL	$32.0 - $47.43 $275,168 - $407,850	-8,599 Reduced 91.48%	801 $33,000
Q3 2018 Nov 07, 2018	BUY	$47.1 - $62.7 $385,937 - $513,763	8,194 Added 679.44%	9,400 $442,000
Q1 2018 May 11, 2018	SELL	$17.2 - $34.95 $335,296 - $681,315	-19,494 Reduced 94.17%	1,206 $37,000
Q3 2017 Oct 17, 2017	BUY	$4.7 - $11.7 $97,290 - $242,189	20,700	20,700 $242,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account